Chinese pathologic consensus for standard diagnosis of gastrointestinal and pancreatic neuroendocrine neoplasm

Chinese Journal of Pathology

Volumn 40, Issue 4, 2011, Pages 257-262

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGRANIN A; KI 67 ANTIGEN; SYNAPTOPHYSIN; TUMOR MARKER;

ARTICLE; CANCER STAGING; CLASSIFICATION; CONSENSUS DEVELOPMENT; GASTROINTESTINAL TUMOR; HUMAN; LYMPH NODE METASTASIS; METABOLISM; NEUROENDOCRINE TUMOR; PANCREAS TUMOR; PATHOLOGY; STANDARD; TUMOR VOLUME;

CHROMOGRANIN A; GASTROINTESTINAL NEOPLASMS; HUMANS; KI-67 ANTIGEN; LYMPHATIC METASTASIS; NEOPLASM STAGING; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; PATHOLOGY, CLINICAL; SYNAPTOPHYSIN; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 79955578469     PISSN: 05295807     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0529-5807.2011.04.010     Document Type: Article

References (12)

1. Yaov JC, Hassan M, Phan A, et al. One hundred years after " carcinoid ": epidemiology of and prognostic factors for neuroendocrine tumors in 35, 825 cases in the United States. J Clin Oncol, 2008, 26(18):3063-3072.
2. Yao JC, Shah MH, Ito T, et al. Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med, 2011, 364(6) :514-523.
3. Raymond E, Dalian L, Raoul JL, et al. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N Engl J Med, 2011, 36(6) :501-513.
4. Klöppel G, Couvelard A, Perren A, et al. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. Neuroendocrinology, 2009, 90(2): 162-166.
5. Klimstra DS, Modlin IR, Adsay NV, et al. Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set. Am J Surg Pathol, 2010, 34(3) :300-313.
6. Bosnian FT, Cameiro F, Hruban RH, et al. WHO classification of tumours of the digestive system. Lyon: IARC Press, 2010.
7. Obemdorfer S. Karzinoide tumoren des dunndarms. Franlcf Z Patrol, 1907, 1:426-432.
8. Williams ED, Siebenmann RE, Sobin LH. Histological typing of endocrine tumours. Geneva:World Health Organization, 1980.
9. Hamilton SR, Aaltonen LA. World Health Organization classification of tumours. Pathology and genetics of tumours of the digestive system. Lyon: IARC Press, 2000.
10. Rindi G, Klöppel G, Alhman H, et al. TNM staging of foregut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch, 2006, 449(4) :395-401. (Pubitemid 44451313)
11. Rindi G, Klöppel G, Couvelard A, et al. TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch, 2007, 451 (4) :757-762. (Pubitemid 47497934)
12. Volante M, Brizzi MP, Faggiano A, et al. Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy. Mod Pathol, 2007, 20( 11) : 1172-1182. (Pubitemid 47609066)